Clover Health Files 8-K for Reg FD and Financials
Ticker: CLOV · Form: 8-K · Filed: Oct 9, 2025 · CIK: 1801170
| Field | Detail |
|---|---|
| Company | Clover Health Investments, Corp. /De (CLOV) |
| Form Type | 8-K |
| Filed Date | Oct 9, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, financials, corporate-update
Related Tickers: CLOV
TL;DR
CLOV filed an 8-K on Oct 9, 2025, covering Reg FD and financials. Address updated.
AI Summary
Clover Health Investments, Corp. filed an 8-K on October 9, 2025, to report on Regulation FD Disclosure and Financial Statements and Exhibits. The filing indicates the company's principal executive offices are located at 30 Montgomery Street, Jersey City, NJ 07302. Clover Health Investments, Corp. was formerly known as Social Capital Hedosophia Holdings Corp. III.
Why It Matters
This 8-K filing provides updates on Clover Health's regulatory disclosures and financial reporting, which are crucial for investors to assess the company's current standing and compliance.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for disclosures and exhibits, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- CLOVER HEALTH INVESTMENTS, CORP. (company) — Registrant
- Social Capital Hedosophia Holdings Corp. III (company) — Former company name
- 30 MONTGOMERY STREET, JERSEY CITY, NJ 07302 (location) — Principal Executive Offices
- October 9, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing for Clover Health Investments, Corp.?
The primary purpose of this 8-K filing is to report on Regulation FD Disclosure and Financial Statements and Exhibits.
On what date was the earliest event reported in this filing?
The earliest event reported in this filing was on October 9, 2025.
What is the current principal executive office address for Clover Health Investments, Corp.?
The principal executive office address is 30 Montgomery Street, Jersey City, NJ 07302.
What were Clover Health Investments, Corp.'s former company names?
Clover Health Investments, Corp. was formerly known as Social Capital Hedosophia Holdings Corp. III.
What is the state of incorporation for Clover Health Investments, Corp.?
The state of incorporation for Clover Health Investments, Corp. is Delaware.
Filing Stats: 649 words · 3 min read · ~2 pages · Grade level 11.1 · Accepted 2025-10-09 16:56:28
Key Financial Figures
- $0.0001 — stered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market
Filing Documents
- clov-20251009.htm (8-K) — 28KB
- axex991xpressreleaseofthec.htm (EX-99.1) — 19KB
- 0001801170-25-000253.txt ( ) — 159KB
- clov-20251009.xsd (EX-101.SCH) — 2KB
- clov-20251009_lab.xml (EX-101.LAB) — 22KB
- clov-20251009_pre.xml (EX-101.PRE) — 13KB
- clov-20251009_htm.xml (XML) — 2KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On October 9, 2025, Clover Health Investments, Corp. (the "Company") issued a press release commenting on the Centers for Medicare & Medicaid Services ("CMS") release of its 2026 Star Ratings for the Company's Medicare Advantage ("MA") plans. CMS has awarded the Company's PPO MA plans with 3.5 Stars and the Company's HMO MA plan with 4.0 Stars. The 2026 Star ratings affect the payment year 2027. A copy of the complete press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information set forth in this Item 7.01 (including the press release in Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) List of Exhibits Exhibit No. Description 99.1 Press Release of the Company, dated October 9, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Clover Health Investments, Corp. Date: October 9, 2025 By: /s/ Peter Kuipers Name: Peter Kuipers Title: Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)